Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma
JAMA Surgery · 2024
DOI: 10.1001/jamasurg.2024.1184 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JAMA Surgery, 2024. Verfasst von Alessandro Vitale und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padova, Second General Surgical Unit, Padova Teaching Ho…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatectomy, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance The 2022 Barcelona Clinic Liver Cancer algorithm currently discourages liver resection (LR) for patients with multinodular hepatocellular carcinoma (HCC) presenting with 2 or 3 nodules that are each 3 cm or smaller.
Objective
To compare the efficacy of liver resection (LR), percutaneous radiofrequency ablation (PRFA), and transarterial chemoembolization (TACE) in patients with multinodular HCC. Design, Setting, and Participants This cohort study is a retrospective analysis conducted using data from the HE.RC.O.LE.S register (n = 5331) for LR patients and the ITA.LI.CA database (n = 7056) for PRFA and TACE patients. A matching-adjusted indirect comparison (MAIC) method was applied to balance data and potential confounding factors between the 3 groups. Included were patients from multiple centers from 2008 to 2020; data were analyzed from January to December 2023.
Interventions
LR, PRFA, or TACE. Main Outcomes and Measures Survival rates at 1, 3, and 5 years were calculated. Cox MAIC-weighted multivariable analysis and competing risk analysis were used to assess outcomes.
Results
A total of 720 patients with early multinodular HCC were included, 543 males (75.4%), 177 females (24.6%), and 350 individuals older than 70 years (48.6%). There were 296 patients in the LR group, 240 who underwent PRFA, and 184 who underwent TACE. After MAIC, LR exhibited 1-, 3-, and 5-year survival rates of 89.11%, 70.98%, and 56.44%, respectively. PRFA showed rates of 94.01%, 65.20%, and 39.93%, while TACE displayed rates of 90.88%, 48.95%, and 29.24%. Multivariable Cox survival analysis in the weighted population showed a survival benefit over alternative treatments (PRFA vs LR: hazard ratio [HR], 1.41; 95% CI, 1.07-1.86; P = .01; TACE vs LR: HR, 1.86; 95% CI, 1.29-2.68; P = .001). Competing risk analysis confirmed a lower risk of cancer-related death in LR compared with PRFA and TACE. Conclusions and Relevance For patients with early multinodular HCC who are ineligible for transplant, LR should be prioritized as the primary therapeutic option, followed by PRFA and TACE when LR is not feasible. These findings provide valuable insights for clinical decision-making in this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padova, Second General Surgical Unit, Padova Teaching Hospital, Padua, Italy.
- Department of General and Transplant Surgery, Grande Ospedale Metropolitano Niguarda, School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
- Department of Gastroenterologiy and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, Italy.
- Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Section of Gastroenterology & Hepatology, University of Palermo, Palermo, Italy.
- Department of Medicine and Surgery, Infectious Diseases and Hepatology Unit, University of Parma and Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
- Division of Internal Medicine, Hepatobiliary and Immunoallergic Disease, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Zitieren
APA
Vitale, A., Romano, P., Cillo, U., Writing Group for the HE.RC.O.LE.S Collaborative Group, Writing Group for the ITA.LI.CA Collaborative Group, HE.RC.O.LE.S and ITA.LI.CA Collaborative Groups, Lauterio, A., Sangiovanni, A., Cabibbo, G., Missale, G., Marseglia, M., Trevisani, F., Foschi, F. G., Cipriani, F., Famularo, S., Marra, F., Saitta, C., Serenari, M., Vidili, G., …, & Baiocchi, G. L. (2024). Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma. JAMA Surgery. https://doi.org/10.1001/jamasurg.2024.1184
Vancouver
Vitale A, Romano P, Cillo U, Writing Group for the HE.RC.O.LE.S Collaborative Group, Writing Group for the ITA.LI.CA Collaborative Group, HE.RC.O.LE.S and ITA.LI.CA Collaborative Groups, et al. Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma. JAMA Surgery. 2024. doi:10.1001/jamasurg.2024.1184
BibTeX
@article{Vitale2024,
author = {Vitale, Alessandro and Romano, Pierluigi and Cillo, Umberto and Writing Group for the HE.RC.O.LE.S Collaborative Group, Writing Group for the HE.RC.O.LE.S Collaborative Group and Writing Group for the ITA.LI.CA Collaborative Group, Writing Group for the ITA.LI.CA Collaborative Group and HE.RC.O.LE.S and ITA.LI.CA Collaborative Groups, HE.RC.O.LE.S and ITA.LI.CA Collaborative Groups and Lauterio, Andrea and Sangiovanni, Angelo and Cabibbo, Giuseppe and Missale, Gabriele and Marseglia, Mariarosaria and Trevisani, Franco and Foschi, Francesco Giuseppe and Cipriani, Federica and Famularo, Simone and Marra, Fabio and Saitta, Carlo and Serenari, Matteo and Vidili, Gianpaolo and Morisco, Filomena and Caturelli, Eugenio and Mega, Andrea and Pelizzaro, Filippo and Nicolini, Daniele and Ardito, Francesco and Garancini, Mattia and Masotto, Alberto and Baroni, Gianluca Svegliati and Azzaroli, Francesco and Giannini, Edoardo and Perri, Pasquale and Scarinci, Andrea and Fontana, Andrea Pierluigi and Brunetto, Maurizia Rossana and Iaria, Maurizio and Di Marco, Maria and Nardone, Gerardo and Dominioni, Tommaso and Lai, Quirino and Ferrari, Cecilia and Rapaccini, Gian Ludovico and Rodolfo, Sacco and Romano, Maurizio and Conci, Simone and Zoli, Marco and Conticchio, Maria and Zanello, Matteo and Zimmitti, Giuseppe and Fumagalli, Luca and Troci, Albert and Germani, Paola and Gasbarrini, Antonio and La Barba, Giuliano and De Angelis, Michela and Patauner, Stefan and Molfino, Sarah and Zago, Mauro and Pinotti, Enrico and Frigo, Anna Chiara and Baiocchi, Gian Luca},
title = {Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma},
journal = {JAMA Surgery},
year = {2024},
doi = {10.1001/jamasurg.2024.1184}
}
EUVIMED